More than a century ago, CSL, the parent company of Seqirus, made a promise to help save lives and protect the health of people stricken with a range of serious and chronic
Today, at Seqirus, that same promise lives on as strong as ever.
Seqirus' world-class commercial operations combined with a flu-focused research and development team enable us to identify, develop, and deliver flu vaccines and treatments that help protect and save lives.
We're driven by our passion and commitment to patients and stakeholders we serve around
While much has changed at CSL since [CSL was established in] 1916, one thing
has not: Our focus on patients. We have earned a reputation over the years as a passionate yet responsible organization driven by our promise to care for the people who rely on our innovative biotherapies. The future has never been
brighter for our organization, our people, and our patients.1
Seqirus is the only major manufacturer with the flexibility of 2 production technologies to develop seasonal influenza vaccines.
Reference: 1. Seqirus: A CSL Company. http://www.seqirus.com/about.
Accessed April 25, 2016.
FLUCELVAX QUADRIVALENT is a vaccine that helps protect against influenza (flu). FLUCELVAX QUADRIVALENT is for people aged 4 and older. Vaccination with FLUCELVAX QUADRIVALENT may not protect all people who receive the vaccine.
You should not get FLUCELVAX QUADRIVALENT if you have had a severe allergic reaction to any of the ingredients in the vaccine